Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy D Isaacs

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Neuroimage|February 8, 2020
Quasi-diffusion magnetic resonance imaging (QDI): A fast, high b-value diffusion imaging techniqueThomas R Barrick, Catherine A Spilling, Carson Ingo, et al.
Journal of Neuropathology and Experimental Neurology|January 27, 2022
Vasculocentric Axonal NfH in Small Vessel DiseaseAdam Anad, Miriam K Barker, Jessica A Katanga, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 18, 2024
Estimating demand for potential disease-modifying therapies for Alzheimer's disease in the UKAxel A S Laurell, Ashwin V Venkataraman, Tatjana Schmidt, et al.
Journal of Proteome Research|June 8, 2007
Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidatesAnnette Dalrymple, Edward J Wild, Richard Joubert, et al.
Cerebral Circulation - Cognition and Behavior|November 3, 2022
What does aducanumab treatment of Alzheimer's disease mean for research on vascular cognitive disorders?Anders Wallin, Suvarna Alladi, Sandra E Black, et al.
Trials|May 24, 2017
Perfusion by Arterial Spin labelling following Single dose Tadalafil In Small vessel disease (PASTIS): study protocol for a randomised controlled trialMathilde M H Pauls, Natasha Clarke, Sarah Trippier, et al.
BMC Medicine|January 26, 2017
Translational models for vascular cognitive impairment: a review including larger speciesAtticus H Hainsworth, Stuart M Allan, Johannes Boltze, et al.
Alzheimer'S Research & Therapy|October 27, 2017
The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's diseaseCraig W Ritchie, Tom C Russ, Sube Banerjee, et al.
Alzheimer'S Research & Therapy|August 1, 2018
Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's diseaseCraig W Ritchie, Tom C Russ, Sube Banerjee, et al.
Brain : a Journal of Neurology|August 16, 2021
Reply: Functional cognitive disorder: dementia's blind spotHarriet A Ball, Laura McWhirter, Clive Ballard, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Neuroimage|February 8, 2020
Quasi-diffusion magnetic resonance imaging (QDI): A fast, high b-value diffusion imaging techniqueThomas R Barrick, Catherine A Spilling, Carson Ingo, et al.
Journal of Neuropathology and Experimental Neurology|January 27, 2022
Vasculocentric Axonal NfH in Small Vessel DiseaseAdam Anad, Miriam K Barker, Jessica A Katanga, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 18, 2024
Estimating demand for potential disease-modifying therapies for Alzheimer's disease in the UKAxel A S Laurell, Ashwin V Venkataraman, Tatjana Schmidt, et al.
Journal of Proteome Research|June 8, 2007
Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidatesAnnette Dalrymple, Edward J Wild, Richard Joubert, et al.
Cerebral Circulation - Cognition and Behavior|November 3, 2022
What does aducanumab treatment of Alzheimer's disease mean for research on vascular cognitive disorders?Anders Wallin, Suvarna Alladi, Sandra E Black, et al.
Trials|May 24, 2017
Perfusion by Arterial Spin labelling following Single dose Tadalafil In Small vessel disease (PASTIS): study protocol for a randomised controlled trialMathilde M H Pauls, Natasha Clarke, Sarah Trippier, et al.
BMC Medicine|January 26, 2017
Translational models for vascular cognitive impairment: a review including larger speciesAtticus H Hainsworth, Stuart M Allan, Johannes Boltze, et al.
Alzheimer'S Research & Therapy|October 27, 2017
The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's diseaseCraig W Ritchie, Tom C Russ, Sube Banerjee, et al.
Alzheimer'S Research & Therapy|August 1, 2018
Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's diseaseCraig W Ritchie, Tom C Russ, Sube Banerjee, et al.
Brain : a Journal of Neurology|August 16, 2021
Reply: Functional cognitive disorder: dementia's blind spotHarriet A Ball, Laura McWhirter, Clive Ballard, et al.
Pageof 5